HIGHLIGHTS
- who: Yuerong Jiang and Keji Chen from the Sciences, Beijing, China, Graduate School of Beijing University of Chinese Medicine, Beijing, China have published the research work: Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis, in the Journal: (JOURNAL) of Apr/26,/2022
- what: Compared with prasugrel, ticagrelor might have a stronger platelet inhibition effect, with a lower incidence of HTPR and a higher incidence of LTPR and bleeding BARC type 1, while there might be no significant difference in the risk Strengths and Limitations There are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.